title: Case series of cetuximab monotherapy for patients with pre-treated colorectal cancer complicated with hyperbilirubinemia due to severe liver metastasis.
authors: Kohei
authors: K
authors: Shitara
authors: Daisuke
authors: D
authors: Takahari
authors: Tomoya
authors: T
authors: Yokota
authors: Takashi
authors: T
authors: Shibata
authors: Takashi
authors: T
authors: Ura
authors: Kei
authors: K
authors: Muro
authors: Yoshitaka
authors: Y
authors: Inaba
authors: Hidekazu
authors: H
authors: Yamaura
authors: Yozo
authors: Y
authors: Sato
authors: Mina
authors: M
authors: Najima
authors: Setsuo
authors: S
authors: Utsunomiya
mesh_terms: D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D000068818:Cetuximab; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D066246:ErbB Receptors / Q000037:antagonists & inhibitors; D005240:Feasibility Studies; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology*; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000556:secondary; D008875:Middle Aged; D009367:Neoplasm Staging; D011379:Prognosis; D012189:Retrospective Studies; D015996:Survival Rate; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000970:Antineoplastic Agents; D066246:ErbB Receptors; D000068818:Cetuximab